FT
AZN icon

Fiduciary Trust’s AstraZeneca AZN Stock Holding History

Fiduciary Trust’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.26M Sell
6,755
-42
-0.6% -$7.9K 0.01% 373
2026
Q1 		$1.32M Buy
6,797
+185
+3% +$35.7K 0.02% 362
2025
Q4 		$1.22M Buy
6,612
+46
+0.7% +$8.07K 0.01% 371
2025
Q3 		$1.01M Buy
6,566
+566
+9% +$85.7K 0.01% 413
2025
Q2 		$839K Sell
6,000
-125
-2% -$17.5K 0.01% 440
2025
Q1 		$900K Buy
6,125
+513
+9% +$74.2K 0.01% 409
2024
Q4 		$735K Buy
5,612
+2,020
+56% +$283K 0.01% 411
2024
Q3 		$560K Buy
3,592
+56
+2% +$9.04K 0.01% 458
2024
Q2 		$551K Buy
3,536
+289
+9% +$43.5K 0.01% 437
2024
Q1 		$440K Sell
3,247
-109
-3% -$14.4K 0.01% 476
2023
Q4 		$452K Buy
3,356
+224
+7% +$29.1K 0.01% 463
2023
Q3 		$424K Buy
3,132
+4
+0.1% +$546 0.01% 466
2023
Q2 		$448K Buy
3,128
+5
+0.2% +$736 0.01% 465
2023
Q1 		$433K Sell
3,123
-1,026
-25% -$138K 0.01% 469
2022
Q4 		$563K Buy
4,149
+57
+1% +$7.15K 0.01% 433
2022
Q3 		$449K Sell
4,092
-689
-14% -$87.4K 0.01% 444
2022
Q2 		$632K Sell
4,781
-27
-0.6% -$3.54K 0.01% 408
2022
Q1 		$638K Buy
4,808
+58
+1% +$6.96K 0.01% 430
2021
Q4 		$554K Sell
4,750
-53
-1% -$6.24K 0.01% 458
2021
Q3 		$577K Buy
4,803
+662
+16% +$77.1K 0.01% 445
2021
Q2 		$496K Buy
4,141
+256
+7% +$28.1K 0.01% 470
2021
Q1 		$387K Hold
3,885
– – 0.01% 493
2020
Q4 		$389K Buy
+3,885
New +$411K 0.01% 466

Other funds holding AZN

EP
Evelyn Partners London $46.9B AUM
IA
Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fiduciary Trust's AZN Position: Q2 2026 in Review

Fiduciary Trust reduced its AstraZeneca (AZN) stake by 0.62% in Q2 2026, selling an estimated $7.9K and leaving 6,755 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #373.

Fiduciary Trust first reported a position in AZN in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.32M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Fiduciary Trust held 6,755 shares of AstraZeneca worth $1.26M as of Q2 2026.
  • Fiduciary Trust sold 42 AstraZeneca shares in Q2 2026, an estimated $7.9K.
  • AstraZeneca made up 0.01% of Fiduciary Trust's portfolio in Q2 2026, its #373 holding.
  • Fiduciary Trust first reported a position in AstraZeneca in Q4 2020 and has held it in 23 quarters since.
  • Fiduciary Trust's AstraZeneca position peaked at $1.32M in Q1 2026.
  • 1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.